Skip to main content
Year archive

Mezzion Pharma Co., Ltd. — 2023 filings

All 41 regulatory filings released by Mezzion Pharma Co., Ltd. (140410) in 2023, sourced directly from the official regulator.

41 Filings
2023 Period
2023 filings (41)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-22 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-22 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-12-05 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information
2023-10-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-10-13 Korean
투자판단관련주요경영사항(임상시험계획변경승인신청)(폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험 계획 변경승인 신청)
Regulatory Filings
2023-09-26 Korean
[기재정정]금전대여결정
Capital/Financing Update
2023-09-20 Korean
주주총회소집결의(임시주주총회)
AGM Information
2023-09-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-09-20 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-11 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2023-06-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-06-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-06-12 Korean
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification
2023-05-31 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-05-04 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-04-19 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-31 Korean
[기재정정]감사보고서제출
Audit Report / Information FY 2022
2023-03-27 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-23 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-22 Korean
투자판단관련주요경영사항(폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험계획 승인)
Regulatory Filings
2023-03-21 Korean
[기재정정]주주총회소집결의
AGM Information
2023-03-21 Korean
[기재정정]주주총회소집공고
AGM Information
2023-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-16 Korean
주주총회소집결의
AGM Information
2023-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-03-16 Korean
주주총회집중일개최사유신고
AGM Information
2023-03-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-02-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-02-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-02-22 Korean
[기재정정]투자판단관련주요경영사항(폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험계획 신청)
Regulatory Filings
2023-02-21 Korean
투자판단관련주요경영사항(폰탄환자치료제 유데나필의 임상3상(추가 임상) 임상시험계획 신청)
Regulatory Filings
2023-02-20 Korean